The global contraceptive market had a size of USD 24.61 billion in 2022. It is projected to expand significantly and reach USD 45.24 billion by 2032, with a forecasted revenue compound annual growth rate (CAGR) of 7% during the same period. Several key factors contribute to this market growth, including the increasing prevalence of Sexually Transmitted Infections (STIs), growing awareness about...

The global Wolman Disease Treatment Market is projected to experience a consistent revenue CAGR in the forecast period. The significant growth in market revenue during this period can be attributed to the increased adoption of Enzyme replacement treatment and the presence of a considerable untreated patient population. Wolman disease, also known as Lysosomal acid lipase deficiency, is a rare...